检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘淼 刘红[1] 乔娇娇 张国瑞[1] LIU Miao;LIU Hong;QIAO Jiaojiao;ZHANG Guorui(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
机构地区:[1]郑州大学第一附属医院呼吸与危重症医学科,河南省郑州市450052
出 处:《实用心脑肺血管病杂志》2025年第3期1-9,共9页Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基 金:国家重点研发计划精准医学研究专项(2016YFC0901100)。
摘 要:结节病是可累及全身的免疫相关疾病,其发病原因仍然未知,病程不可预测,临床表现缺乏特异性。目前系统性糖皮质激素仍是治疗结节病的首选方式,部分患者可加用细胞毒类药物。另外,随着对疾病认知的加深,一些新兴的生物标志物被发现可以辅助诊治结节病。本文综述了结节病诊断及治疗的进展,以期提高临床对结节病诊断、鉴别诊断及治疗的认识。Sarcoidosis is an immune related disease that can affect the whole body,and its etiology is still unknown,the course of the disease is unpredictable,and the clinical manifestations lack specificity.At present,systemic corticosteroids are still the preferred treatment for sarcoidosis,and some patients may be treated with cytotoxic drugs.In addition,with the deepening of understanding of the disease,some emerging biomarkers have been discovered to assist in the diagnosis and treatment of sarcoidosis.This article reviews the progress in the diagnosis and treatment of sarcoidosis,with the aim of improving clinical understanding of the diagnosis,differential diagnosis,and treatment of sarcoidosis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.63